Melindo, Emmalyn A.

HRN: 22-32-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2023
CEFUROXIME 1.5GM (VIAL)
01/09/2023
01/16/2023
IV
1.5GMS
Q8h
S/P LTCS, MSAF
Waiting Final Action 
01/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/09/2023
01/16/2023
IV
500 MG
Q8h
S/P LTCS, MSAF
Waiting Final Action 
01/10/2023
CEFUROXIME 500MG (TAB)
01/10/2023
01/16/2023
ORAL
500
BID
LTCS
Waiting Final Action 
01/10/2023
METRONIDAZOLE 500MG (TAB)
01/10/2023
01/17/2023
ORAL
500
TID
Prom
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: